Ethiopia medical device regulations

The classification guideline for devices other than IVDs: the four risk classes and the rules that assign a device to one. Version 002, approved 20.06.2026, effective 30.06.2026; version 001 was first issued in 2021. Two things about the copy are worth recording because they are the source's and are not repaired: the file name says "V1" while the document itself is Version 002 (the file name is the publisher's), and the file name also spells the Authority "EEDA" against the `EFDA` the document uses throughout. Its body headings are the one set a generic heading scan could not see at all, which is why this market's extracts are TOC-driven.

The labelling guideline: what must appear on the label, the instructions for use and the packaging of a medical device placed on the Ethiopian market. Version 002, approved 01.06.2026, effective 30.06.2026; version 001 was first issued in 2021. Its contents and its body disagree by two from Scope onwards — the contents writes 3 Scope, 4 Objective, 5 labelling requirements while the body prints 1. Scope, 2. Objective, 3. labelling requirements — and the contents also lists "1.1. Exemptions from labelling requirements" out of place in the 6.5 area. The extract carries the body's numbering; the contents' numbering is the source's error and is reported, not corrected.

The post-market vigilance guideline: adverse-event and incident reporting, the reporting routes and timelines, and the surveillance the Authority carries out — the guideline that the Directive's vigilance obligations are worked through. Version 001, approved 15.06.2026, effective 30.06.2026, and the only version: this guideline was first issued in 2026, unlike its siblings. Its cover and Document History say version 001 while the running footer of the copy says "Version No: 002"; the extract carries the document as published and the record follows the cover and the history table (Version No: 001 in the code field), with the footer discrepancy stated here rather than silently preferring one.

The abridged route for low-risk devices: what a low-risk application must contain and how it is handled, with the checklists and forms the Authority issues for it. Version 002, approved 20.06.2026, effective 30.06.2026, first issued 2022. Its contents leaders with ellipsis characters rather than periods and its contents numbering is one ahead of its body: the contents reads 1 INTRODUCTION / 2 OBJECTIVE / 3 SCOPE while the body prints a bare "INTRODUCTION" and then "1 OBJECTIVE" and "2 SCOPE". The extract labels each block with the number the body prints and leaves the disagreement standing.

The registration-requirements guideline for devices other than IVDs: what the technical file must contain, section by section. Version 002, approved 15.06.2026, effective 30.06.2026, first issued 2022. It is the longest of the eight guidelines and the one whose own numbering is least tidy: its contents breaks across a page boundary (the extract's contents reader had to accept an eight-line blank run inside the contents itself), it prints chapters as an unnumbered level (`CHAPTER ONE` … `CHAPTER FIVE`, plus `6A`, `6B` and `ANNEX-I`), and its body reaches `4.2.3` with no `4.2` and restarts at `1.1`/`2.1` under section 5. All of that is reproduced as printed; the extract holds 87 located sections and reconciles nothing.

The variations guideline: which changes to a registered device must be notified to the Authority after approval, how the notification is made, and what the Authority does with it. Version 002, approved 21.06.2026, effective 30.06.2026; version 001 was first issued in 2021. The shortest of the eight guideline expressions (its contents lists eight sections and it carries the notification form as its last section), which is why its extract holds nine blocks.

The master marketing-authorization guideline: the application route, the dossier the Authority expects, how the application is screened and assessed, the decision and the certificate, with the annexes that carry the templates. Version 005, approved 05.06.2026 with an effective date of 25.06.2026 and a first issue date of 2022; the Document History table runs 001 (new guideline, 2022) through 005, so this version supersedes the third-edition guideline the earlier batch triage pointed at. The extract keeps 55 body sections located from the document's own contents, including the annexes (`ANNEX I` to `ANNEX V`, one of which is the application letter template), and the block labels are the numbers the body headings print — the contents writes "Annex III:- Application letter template" with a colon and a dash, which is the source's spelling and is not normalised.

EFDA's reliance guideline: when the Authority will take account of a decision or an assessment already made by a trusted regulator instead of assessing the application itself, the reliance pathways it recognises, and the documentation a reliance application needs. Version 003, approved 02/12/2024 and effective the same day, first issued 20/12/2021, with version 002 effective 01/01/2024. It is NOT a device instrument: it is written for medicines marketing authorization, and it is filed in this market because it is an EFDA reliance instrument in the declared set and because reliance policy is read across product lines — the batch triage note described the lead as a device text, and this record corrects that in its own summary rather than by omission. Its body prints sections 11 and 13 unnumbered where the contents numbers them, and prints "10.1. Application Submission" only in the contents; the extract follows the body.

The one legal instrument in this market's declared set: the EFDA Directive that controls who may import, export and wholesale medicines and medical devices in Ethiopia. It is signed October 22, 2021 by Heran Gerba, Director General, and registered as Directive No. 872/2014 in the Ethiopian calendar (872/2022 in the Gregorian style the file carries). Its own Article 44 states that it "shall enter into force on the date of 08 January, 2021" — a date EARLIER than its own signature month; the text is recorded as written and the discrepancy is not repaired. Article 42 repeals the Medicines and medical equipment importer and wholesalers, exporter control directive No. 10/2005 and Ministry of Justice directive No. 350/2013. It is a bilingual document: the Amharic and English texts are printed in parallel columns through the operative articles, and the annexes are English-only tables. The corpus therefore holds two extracts under this one id — `directive-872-2022-import-export-wholesale-am` (43 articles plus the preamble) and `directive-872-2022-import-export-wholesale-en` (42 articles, Annexes 1-3 and the preamble) — off one source file, one SHA-256 and one official code. Contract rule 6 is why both are recorded: an authority-hosted second language is valid provenance at its own language path and does not replace the controlling text. No publication date is stated by the document (the batch declaration records published = null); the JO-equivalent date is not invented here.